Macquarie Group
SAGE

Macquarie Group’s Sage Therapeutics SAGE Stock Holding History

Macquarie Group’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,637
Closed -$139K – 2068
2022
Q3 		$139K Sell
2,637
-93
-3% -$3.6K ﹤0.01% 1684
2022
Q2 		$88K Hold
2,730
– – ﹤0.01% 1898
2022
Q1 		$90K Hold
2,730
– – ﹤0.01% 1982
2021
Q4 		$116K Sell
2,730
-633
-19% -$26.5K ﹤0.01% 1888
2021
Q3 		$149K Buy
3,363
+1,685
+100% +$77.3K ﹤0.01% 1860
2021
Q2 		$95K Sell
1,678
-22
-1% -$1.55K ﹤0.01% 1986
2021
Q1 		$127K Sell
1,700
-547
-24% -$44.8K ﹤0.01% 1835
2020
Q4 		$194K Hold
2,247
– – ﹤0.01% 1672
2020
Q3 		$137K Hold
2,247
– – ﹤0.01% 1704
2020
Q2 		$93K Buy
2,247
+547
+32% +$19.9K ﹤0.01% 1774
2020
Q1 		$49K Sell
1,700
-21,041
-93% -$1.22M ﹤0.01% 1819
2019
Q4 		$1.64M Hold
22,741
– – ﹤0.01% 1095
2019
Q3 		$3.19M Hold
22,741
– – 0.01% 882
2019
Q2 		$4.16M Buy
22,741
+4,169
+22% +$711K 0.01% 822
2019
Q1 		$2.95M Sell
18,572
-220
-1% -$31.9K 0.01% 893
2018
Q4 		$1.8M Buy
18,792
+5,995
+47% +$686K ﹤0.01% 988
2018
Q3 		$1.81M Sell
12,797
-703
-5% -$109K ﹤0.01% 1033
2018
Q2 		$2.11M Buy
13,500
+10,676
+378% +$1.68M ﹤0.01% 986
2018
Q1 		$455K Buy
+2,824
New +$479K ﹤0.01% 1419

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Macquarie Group's SAGE Position: Q4 2022 in Review

Macquarie Group sold out of Sage Therapeutics (SAGE) in Q4 2022, closing a stake of 2,637 shares — an estimated $139K sold.

Macquarie Group first reported a position in SAGE in Q1 2018 and held it in 19 quarters. The position peaked at $4.16M in Q2 2019. 206 funds tracked by Wall St. Rank hold SAGE as of Q4 2022.

  • Macquarie Group reported no remaining Sage Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Macquarie Group sold 2,637 Sage Therapeutics shares in Q4 2022, an estimated $139K.
  • Macquarie Group first reported a position in Sage Therapeutics in Q1 2018 and held it in 19 quarters.
  • Macquarie Group's Sage Therapeutics position peaked at $4.16M in Q2 2019.
  • 206 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.